Back to top
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Image: Bigstock
New Strong Buy Stocks for December 30th
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today:
Alarm.Com Holdings, Inc. (ALRM - Free Report) : This provider of cloud-based software platform solutions has witnessed the Zacks Consensus Estimate for its current year earnings increasing 2.6% over the last 30 days.
ALARM.COM HLDGS Price and Consensus
ALARM.COM HLDGS Price and Consensus | ALARM.COM HLDGS Quote
Catabasis Pharmaceuticals, Inc. : This clinical-stage biopharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings advancing 0.6% over the last 30 days.
CATABASIS PHARM Price and Consensus
CATABASIS PHARM Price and Consensus | CATABASIS PHARM Quote
Extended Stay America, Inc. : This owner and operator of hotels in the United States and Canada has witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.2% over the last 30 days.
EXTENDED STAY Price and Consensus
EXTENDED STAY Price and Consensus | EXTENDED STAY Quote
Nivalis Therapeutics, Inc. : This clinical stage pharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings improving 2.9% over the last 30 days.
NIVALIS THERAPT Price and Consensus
NIVALIS THERAPT Price and Consensus | NIVALIS THERAPT Quote
TD Ameritrade Holding Corporation (AMTD - Free Report) : This provider of securities brokerage services and related technology-based financial services has witnessed the Zacks Consensus Estimate for its current year earnings increasing 3.1% over the last 30 days.
TD AMERITRADE Price and Consensus
TD AMERITRADE Price and Consensus | TD AMERITRADE Quote
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Confidential from Zacks
Would you like to see Zacks' best recommendations that are not available to the public? Our Executive VP, Steve Reitmeister, knows when key trades are about to be triggered and which of our experts has the hottest hand. Click to access these private picks >>.